Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Papillomavirus Infections 1Nasopharyngeal Neoplasms 1

Interventions

Radiotherapy, Intensity-Modulated 7Cisplatin 7Carboplatin 5Surveys and Questionnaires 3Paclitaxel 3Taxes 2Radiation 2Docetaxel 2Cetuximab 2Albumin-Bound Paclitaxel 2utomilumab 1toripalimab 1infigratinib 1fludarabine phosphate 1fludarabine 1durvalumab 1aldesleukin 1Specimen Handling 1Radiotherapy 1Platinum 1Nimorazole 1Mass Screening 1Liquid Biopsy 1Immunoglobulin G 1Hydroxyurea 1Gene Expression Profiling 1Focus Groups 1Fluorouracil 1Drug Therapy 1Disulfides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Papillomavirus Infections × infigratinib × Head & Neck × Clear all
NCT02706691 2019-04-16

BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer

University of Chicago

Phase 2 Terminated
1 enrolled 8 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡